Skip to main content
Siamak Daneshmand, MD, Urology, Los Angeles, CA, Keck Hospital of USC

SiamakDaneshmandMD

Urology • Los Angeles, CA

Minimally Invasive Surgery, Surgical Oncology

Professor of Urology (Clinical Scholar); Director of Urologic Oncology

Join to view full profile

Dr. Daneshmand is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Daneshmand's full profile

Already have an account?

Summary

  • BIOGRAPHY
    Dr. Sia Daneshmand earned his medical degree at the University of California, Davis and completed his residency at USC followed by a two-year fellowship in Urologic Oncology at the USC/Norris Comprehensive Cancer Center. He was recruited back to USC Institute of Urology in 2010 as Director of Urologic Oncology. He is currently an Associate Professor of Urology with Clinical Scholar designation and serves as director of clinical research as well as the urologic oncology (SUO) fellowship director.
    Dr. Daneshmand’s main interests include bladder cancer, testicular cancer, advanced kidney cancer and prostate cancer. He has extensive experience in urinary diversion and reconstruction following radical cystectomy as well as nerve-sparing retroperitoneal lymph node dissection (RPLND) following chemotherapy for advanced testis cancer. He is one of the highest volume surgeons for this disease on the west coast and has been selected as one of “True Experts” in the Testicular Cancer Resource Center web site. He also has extensive experience in the management of advanced kidney cancers with vena caval tumor thrombus involvement, retroperitoneal sarcomas and surgeries requiring requiring resection of the great vessels. His research interests include the use of pathways to improve peri-operative outcomes and he is a leading authority on enhanced recovery after surgery (ERAS) following radical cystectomy. He serves on the editorial board of the Journal of Urology, the scientific advisory board of Bladder Cancer Advocacy Network (BCAN) as well as the AUA/SUO Guideline Committee on non-muscle invasive bladder cancer. He is a member of Alpha Omega Alpha medical honor society, and has been designated one of the “America’s Top Cancer Doctors” for numerous consecutive years.
    He is an active member of the Society of Urologic Oncology, has presented over 300 abstracts at scientific meetings and has authored over 200 peer-reviewed articles, reviews, and chapters.

Education & Training

  • University of Southern California/LAC+USC Medical Center
    University of Southern California/LAC+USC Medical CenterFellowship, Minimally Invasive Urologic Surgery, 2002 - 2004
  • University of Southern California/LAC+USC Medical Center
    University of Southern California/LAC+USC Medical CenterResidency, Urology, 1996 - 2002
  • University of California, Davis, School of Medicine
    University of California, Davis, School of MedicineClass of 1996
  • University of California, Los Angeles
    University of California, Los AngelesB.S., Microbiology & Molecular Genetics, Magna Cum Laude, 1988 - 1992

Certifications & Licensure

  • OR State Medical License
    OR State Medical License 2004 - Present
  • CA State Medical License
    CA State Medical License 1997 - 2025
  • American Board of Urology Urology

Awards, Honors, & Recognition

  • America's Top Doctors Castle Connolly, 2010-2017
  • America's Top Doctors for Cancer Castle Connolly, 2009-2017
  • Winner Best Poster of Session AUA, 2016
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Frailty as a Predictor of Complications After Radical Cystectomy: A Prospective Study of Various Preoperative Assessments  
    Madeleine L Burg, Anne K Schuckman, Hooman Djaladat, Siamak Daneshmand, Urologic Oncology
  • Urology Photo Quiz: Adrenal myelolipoma  
    Quek ML and Daneshmand S, Resident & Staff Physician, 1/1/2004
  • Placental pathology casebook Complete hydatidiform mole with coexistent term twin pregnancy  
    Albers E, Daneshmand S, Hull A, J Perinatol, 1/1/2001

Books/Book Chapters

  • Upper Tract Urothelial Carcinoma 
    Chapter: The Role of Lymphadenectomy in the Management of Urothelial Carcinoma of the Upper Urinary Tract 
    Kondo T, Bochner B, Daneshmand S, Zlotta ARSpringer2015
  • Mastery of Surgery. 
    Chapter: Radical Cystectomy and Orthotopic Reconstruction for Bladder Cancer. 
    Skinner E, Daneshmand SLippincott, Williams and WilkinsEdition 6th,2012
  • Cancer Medicine 
    Chapter: Neoplasms of the Testis. 
    Kollmannsberger C, Moore C , Daneshmand S, Hayes-Lattin B, Hansen E, Corless C, Nichols CEdition 8th,2011
  • Join now to see all

Abstracts/Posters

  • Baseline GFR and cisplatin-induced renal toxicity in urothelial cancer patients.
    Adrienne Tran, Janice Loh, Lingyun Ji, Siamak Daneshmand, Anne K. Schuckman, Susan G. Groshen, David I. Quinn, Tanya B. Dorff, GU Cancer Syposium, San Francisco, CA, 1/1/2016
  • Development and validation of contouring guidelines for post-cystectomy adjuvant radiation of bladder cancer.
    Brian C. Baumann, Walter Bosch, Amit Bahl, Alison J. Birtle, Rodney H. Breau, Amarnath Challapalli, Albert Chang, Ananya Choudhury, Siamak Daneshmand, Adam S. Feldman,..., GU Cancer Syposium, San Francisco, CA, 1/1/2016
  • Impact of salvage surgery and radiotherapy on overall survival in patients with recurrent primary urethral cancer.
    Georgios Gakis, Todd Matthew Morgan, Siamak Daneshmand, Kirk A. Keegan, Johannes Mischinger, Tina Schubert, Rebecca Helen Clayman, Harras B Zaid, Jan Hrbacek, Bedeir A..., GU Cancer Syposium, San Francisco, CA, 1/1/2016
  • Join now to see all

Lectures

  • 4 day hospital stay following radical cystectomy. Is it feasible in Europe? 
    Lisbon, Portugal - 1/1/2016
  • Urinary Diversion, Bladder Cancer, Upper Tract Urothelial cancer 
    Mclean, VA - 1/1/2016
  • Evaluation of Gastrointestinal Complications Following Radical Cystectomy Using Enhanced Recovery Protocol 
    Washington, DC - 1/1/2016
  • Join now to see all

Other

  • Lymph node dissection in bladder cancer. (Performed radical cystectomy for bladder cancer.) 
    Daneshmand S, Labbafinejad Urology Department
    Shahid Beheshti University of Medical Sciences, Tehran, Iran - 1/1/2014
  • Health Heroes- Blue light cystoscopy 
    Daneshmand S, Discovery Health
    1/1/2013
  • Treatment for Testicular cancer. 
    Daneshmand S, Doctors TV show
    http://www.thedoctorstv.com/videolib/init/8028
    1/1/2012
  • Join now to see all

Authored Content

  • Is Imperative Partial Nephrectomy Feasible for Kidney Cancer with Venous Thrombus Involvement? Outcomes of 42 Cases and Matched Pair Analysis with a Large Radical Nephrectomy CohortMay 2018
  • Is Imperative Partial Nephrectomy Feasible for Kidney Cancer with Venous Thrombus Involvement? Outcomes of 42 Cases and Matched Pair Analysis with a Large Radical Nephrectomy CohortMay 2018
  • Is Imperative Partial Nephrectomy Feasible for Kidney Cancer with Venous Thrombus Involvement? Outcomes of 42 Cases and Matched Pair Analysis with a Large Radical Nephrectomy CohortMay 2018

Press Mentions

  • High Response Rate for TAR-200 plus Cetrelimab in BCG-Unresponsive NMIBC
    High Response Rate for TAR-200 plus Cetrelimab in BCG-Unresponsive NMIBCMay 24th, 2023
  • Novel Chemotherapy Delivery System May Fill Key Gap in Bladder Cancer Treatment
    Novel Chemotherapy Delivery System May Fill Key Gap in Bladder Cancer TreatmentMay 3rd, 2023
  • Novel Chemo Delivery System Achieves High Response Rate in Bladder Cancer
    Novel Chemo Delivery System Achieves High Response Rate in Bladder CancerMay 2nd, 2023
  • Join now to see all

Professional Memberships

Hospital Affiliations

External Links

  • USC Urologyhttp://www.uscurology.com/doctor/bio/view/126223

Dr. Siamak Daneshmand, Dr. Siamak Daneshmand, MD, Dr. S Daneshmand